AVENUE THERAPEUTICS, INC.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 1111 KANE CONCOURSE, BAY HARBOR ISLANDS, FL, 33154
Mailing Address 1111 KANE CONCOURSE, BAY HARBOR ISLANDS, FL, 33154
Phone 781-652-4500
Fiscal Year End 1231
EIN 474113275
Financial Overview
FY2025
$2.67M
Total Assets
$2.85M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 30, 2026 | View on SEC |
| 8-K Current report of material events | February 23, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| 4 Insider stock transaction report | January 6, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | January 6, 2026 | View on SEC |
| 8-K Current report of material events | December 31, 2025 | View on SEC |
| DEF 14A Definitive proxy statement | December 5, 2025 | View on SEC |
| 8-K Current report of material events | November 18, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 13, 2025 | View on SEC |
| 8-K Current report of material events | November 12, 2025 | View on SEC |
Annual Reports
10-K March 30, 2026
- Divested Baergic Bio subsidiary for $10 million to streamline focus on AJ201
- Strategic pivot to prioritize AJ201 for spinal and bulbar muscular atrophy
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.